ArticleEndocrinology, diabetes & metabolism2026
Association of the Endothelial Nitric Oxide Synthase (eNOS) G894T Gene Polymorphism With Type 2 Diabetes Mellitus in a Tunisian Population.
Article in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Association of the Endothelial Nitric Oxide Synthase (eNOS) G894T Gene Polymorphism With Type 2 Diabetes Mellitus in a Tunisian Population.Endocrinology, diabetes & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 Diabetes Mellitus (T2D) is a multifactorial metabolic disorder with a significant genetic component. Endothelial dysfunction, characterised by reduced nitric oxide (NO) bioavailability, is a key pathological feature. The endothelial nitric oxide synthase (eNOS) gene (NOS3) contains several polymorphisms, with the G894T (Glu298Asp) variant being a prominent candidate for influencing disease susceptibility.
objectiveThis study aimed to investigate the association between the eNOS G894T polymorphism and the risk of T2D in a sample of the Tunisian population.
methodsWe conducted a case-control study including 100 T2D patients and 100 non-diabetic controls recruited from the Military Hospital of Tunis. Anthropometric, clinical and biochemical parameters, including lipid profiles and high-sensitivity C-reactive protein (CRPus), were measured. Genotyping of the eNOS G894T polymorphism was performed using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method with the BanII restriction enzyme.
resultsT2D patients exhibited significantly higher levels of triglycerides (1.99 ± 1.27 vs. 1.45 ± 0.65 mmol/L, p = 0.002) and CRPus (2.73 ± 2.47 vs. 1.63 ± 1.42 mg/L, p = 0.003) compared to controls. The frequency of the mutated T allele was significantly higher in the T2D group than in the control group (27.53% vs. 11.27%, p < 10
conclusionThe eNOS G894T polymorphism is a significant genetic risk factor for type 2 diabetes in the studied Tunisian population. The T allele appears to confer susceptibility, likely through mechanisms involving impaired eNOS function, reduced NO production and subsequent endothelial dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.